Amyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Glia

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/glia.22502PMID 23616440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aβ leads to Ca²⁺ signaling alterations and transcriptional changes in glial cells.

  2013cited by this paper
• Aβ-induced Ca(2+) influx regulates astrocytic BACE1 expression via calcineurin/NFAT4 signals.

  2012cited by this paper
• Glial cells in (patho)physiology

  2012cited by this paper
• FOXO3 as a new IKK‐ε‐controlled check‐point of regulation of IFN‐β expression

  2012cited by this paper
• Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology

  2012cited by this paper
• Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease

  2012cited by this paper
• Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

  2012cited by this paper
• Neurological diseases as primary gliopathies: a reassessment of neurocentrism

  2012cited by this paper
• Neuroglial Roots of Neurodegenerative Diseases?

  2011cited by this paper
• Dephosphorylation of Bcl‐10 by calcineurin is essential for canonical NF‐κB activation in Th cells

  2011influential reference
• The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-κB Activation*

  2011influential reference
• Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture

  2011influential reference
• Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease

  2011cited by this paper
• A Role for Calcineurin in Alzheimer’s Disease

  2011influential reference
• β‐Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression

  2011cited by this paper
• Amyloid peptide pores and the beta sheet conformation.

  2010influential reference
• Disparate effects of serum on basal and evoked NFAT activity in primary astrocyte cultures.

  2010cited by this paper
• Calcium Signaling and Amyloid Toxicity in Alzheimer Disease*

  2010cited by this paper
• The dysregulation of intracellular calcium in Alzheimer disease.

  2010cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• β-Amyloid Monomers Are Neuroprotective

  2009cited by this paper
• Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice

  2009cited by this paper
• Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling

  2009cited by this paper
• Astrocyte Function is Modified by Alzheimer's Disease-like Pathology in Aged Mice

  2009cited by this paper
• Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1‐4 and cyclooxygenase‐2 as NFAT target genes

  2008cited by this paper
• Mechanical lesion activates newly identified NFATc1 in primary astrocytes: implication of ATP and purinergic receptors

  2008cited by this paper
• Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.

  2008cited by this paper
• Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells*

  2008cited by this paper
• Interleukin-1β-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity*

  2008influential reference
• Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.

  2007cited by this paper
• Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store

  2007cited by this paper
• Synapse-Associated Protein-97 Mediates α-Secretase ADAM10 Trafficking and Promotes Its Activity

  2007cited by this paper
• Networks

  2007cited by this paper
• Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations.

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme

  2005cited by this paper
• Calcineurin Triggers Reactive/Inflammatory Processes in Astrocytes and Is Upregulated in Aging and Alzheimer's Models

  2005cited by this paper
• Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.

  2005cited by this paper
• Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture.

  2004cited by this paper
• Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease

  2003cited by this paper
• Expression and Cell Distribution of Group I and Group II Metabotropic Glutamate Receptor Subtypes in Taylor‐type Focal Cortical Dysplasia

  2003cited by this paper
• Brain-Derived Neurotrophic Factor Activation of NFAT (Nuclear Factor of Activated T-Cells)-Dependent Transcription: A Role for the Transcription Factor NFATc4 in Neurotrophin-Mediated Gene Expression

  2003cited by this paper
• Gene Structure of the Human Metabotropic Glutamate Receptor 5 and Functional Analysis of Its Multiple Promoters in Neuroblastoma and Astroglioma Cells*

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.

  2001cited by this paper
• Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

  2001cited by this paper
• Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis.

  2000cited by this paper
• Differential cellular expression of isoforms of inositol 1,4,5‐triphosphate receptors in neurons and glia in brain

  1999cited by this paper
• Plasma membrane calcium ATPase isoforms in astrocytes

  1999cited by this paper
• L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons

  1999influential reference
• The Expression of Plasma Membrane Ca2+ Pump Isoforms in Cerebellar Granule Neurons Is Modulated by Ca2+ *

  1999cited by this paper
• Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target

  1998cited by this paper
• Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.

  1998cited by this paper
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper

• BDNF prevents amyloid-β-induced exacerbation of mGluR5-driven Ca2+ transients in astrocytes through TrkB-Tc activation.

  2026cites this paper
• Spontaneous glutamate release activates mGluR signaling to drive rapid antidepressant responses

  2025cites this paper
• Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment.

  2025cites this paper
• AstroWars: the return of the astrocytic metabotropic glutamate receptor 5

  2025cites this paper
• Dynamic modeling of astrocyte-neuron interactions under the influence of Aβ deposition

  2025cites this paper
• Neurotoxic amyloid β‐peptide and tau produce cytokine‐like effects on PMCA in glioblastoma cell lines, enhancing its activity and isoforms expression

  2025cites this paper
• The mGluR5 Agonist, CHPG, Enhances Numbers of Differentiated Human Oligodendrocytes

  2025cites this paper
• Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease.

  2025cites this paper
• Inhibition of astrocyte signaling leads to sex-specific changes in microglia phenotypes in a diet-based model of small cerebral vessel disease

  2025cites this paper
• Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

  2025cites this paper
• Central cytometabolic functional vascular coupling in health and disease

  2025cites this paper
• Linking Circadian Rhythms to Gut‐Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease

  2025cites this paper
• Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome

  2025cites this paper
• Disrupted astrocyte-neuron signaling reshapes brain activity in epilepsy and Alzheimer's disease.

  2025cites this paper
• Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder

  2025influential citation
• Disrupted Calcium Dynamics in Reactive Astrocytes Occur with End Feet–Arteriole Decoupling in an Amyloid Mouse Model of Alzheimer's Disease

  2025cites this paper
• Undaria pinnatifida fucoidan extract inhibits activation of the NF-κB signaling pathway by herpes simplex virus type 1 and prevents amyloid-β peptide synthesis in retinal pigment epithelium cells

  2025cites this paper
• The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation

  2025cites this paper
• Inhibition of astrocyte signaling leads to sex-specific changes in microglia phenotypes in a diet-based model of cerebral small vessel disease

  2025cites this paper
• mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders

  2025cites this paper
• Inflammatory aspects of Alzheimer’s disease

  2024cites this paper
• Alantolactone improves cognitive impairment in rats with Porphyromonas gingivalis infection by inhibiting neuroinflammation, oxidative stress, and reducing Aβ levels.

  2024cites this paper
• Astrocyte-Neuron Interactions in Alzheimer's Disease.

  2024cites this paper
• Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease.

  2024cites this paper
• Efeito da atividade física e do exercício sobre o comprometimento cognitivo leve e a demência: uma revisão da literatura

  2024cites this paper
• Early 1,25-dihydroxyvitamin D3-glycosides supplementation: An efficient feeding strategy against bacterial chondronecrosis with osteomyelitis lameness in broilers assessed by using an aerosol transmission model

  2024cites this paper
• Brain-Penetrant NF-κB and NLRP3 Targeting Nanoligomers are Therapeutic in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD) Human Organoid and Mouse Models

  2024cites this paper
• Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease

  2024cites this paper
• Astroglial activation: Current concepts and future directions

  2024cites this paper
• Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementia

  2024cites this paper
• Blockade of mGluR5 in astrocytes derived from human iPSCs modulates astrocytic function and increases phagocytosis

  2023cites this paper
• Intracellular Ca2+ signalling: unexpected new roles for the usual suspect

  2023cites this paper
• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel Disease

  2023influential citation
• The endoplasmic reticulum stress and unfolded protein response in Alzheimer's disease: a calcium dyshomeostasis perspective.

  2023cites this paper
• Research Advances of Mitochondrial Dysfunction in Perioperative Neurocognitive Disorders

  2023cites this paper
• Optogenetics in Alzheimer’s Disease: Focus on Astrocytes

  2023cites this paper
• Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

  2022cites this paper
• Synaptic dysfunction in early phases of Alzheimer's Disease.

  2022cites this paper
• Combined effects of Aerobic exercise and 40Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3xTg mice.

  2022cites this paper
• Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer’s disease mouse model: a role for ER-mitochondria interaction

  2022cites this paper
• Amyloid polymorphs and pathological diversities.

  2022cites this paper
• Glial Cells in Alzheimer's Disease: From Neuropathological Changes to Therapeutic Implications.

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Immortalized hippocampal astrocytes from 3xTg-AD mice, a new model to study disease-related astrocytic dysfunction: a comparative review

  2022cites this paper
• Role of amyloid beta (25-35) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer's Disease.

  2022cites this paper
• Potential of astrocytes in targeting therapy for Alzheimer's disease.

  2022cites this paper
• Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions

  2022cites this paper
• The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

  2022cites this paper
• Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View

  2022cites this paper
• The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease

  2022cites this paper
• Impaired astrocytic Ca2+ signaling in awake-behaving Alzheimer’s disease transgenic mice

  2022cites this paper
• Calcium signaling in neuroglia.

  2021cites this paper
• Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease

  2021influential citation
• The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease

  2021cites this paper
• Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease

  2021cites this paper
• Impaired astrocytic Ca2+ signalling in awake Alzheimer’s disease transgenic mice

  2021cites this paper
• Unraveling Aβ-Mediated Multi-Pathway Calcium Dynamics in Astrocytes: Implications for Alzheimer’s Disease Treatment From Simulations

  2021cites this paper
• Angiotensin II Disrupts Neurovascular Coupling by Potentiating Calcium Increases in Astrocytic Endfeet

  2021cites this paper
• Impaired Hippocampal Neurovascular Coupling in a Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Early Effects of the Soluble Amyloid β25-35 Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors

  2021cites this paper
• Hypoxia-Induced Neuroinflammation in Alzheimer’s Disease: Potential Neuroprotective Effects of Centella asiatica

  2021cites this paper
• Physiological and Pathological Ageing of Astrocytes in the Human Brain

  2021cites this paper
• Membrane Interactions and Toxicity by Misfolded Protein Oligomers

  2021cites this paper
• Adenosine A2B receptor down‐regulates metabotropic glutamate receptor 5 in astrocytes during postnatal development

  2021cites this paper
• Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease

  2021influential citation
• Amyloid-β (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex.

  2021cites this paper
• The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease

  2021cites this paper
• Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors

  2020cites this paper
• Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders

  2020cites this paper
• Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease

  2020cites this paper
• Roles of glial ion transporters in brain diseases

  2020cites this paper
• Aerobic exercise during exposure to 40Hz light flicker protects against early cognitive impairments in Alzheimer’s disease of 3xTg mice

  2020cites this paper
• The Na+/Ca2+exchanger in Alzheimer's disease.

  2020cites this paper
• Calcineurin Controls Expression of EAAT1/GLAST in Mouse and Human Cultured Astrocytes through Dynamic Regulation of Protein Synthesis and Degradation

  2020cites this paper
• Synaptic plasticity in Alzheimer’s disease and healthy aging

  2020cites this paper
• The Anemonia sulcata Toxin BDS-I Protects Astrocytes Exposed to Aβ1–42 Oligomers by Restoring [Ca2+]i Transients and ER Ca2+ Signaling

  2020cites this paper
• Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease

  2020cites this paper
• Diagnostic and prognostic biomarkers for HAND

  2019cites this paper
• Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis

  2019cites this paper
• Astrocyte function from information processing to cognition and cognitive impairment

  2019cites this paper
• Astrocyte Biomarkers in Alzheimer's Disease.

  2019cites this paper
• Astrocytes in Neuropathologies Affecting the Frontal Cortex

  2019cites this paper
• Small Molecule Natural Products and Alzheimer's Disease.

  2019cites this paper
• Aberrant Calcium Signals in Reactive Astrocytes: A Key Process in Neurological Disorders

  2019cites this paper
• Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

  2019cites this paper
• Astroglial Calcium Signaling in Aging and Alzheimer's Disease.

  2019influential citation
• Oxymatrine can attenuate pathological deficits of Alzheimer's disease mice through regulation of neuroinflammation.

  2019cites this paper
• Calcineurin B1 Deficiency in Glial Cells Reduces Gastrointestinal Motility and Results in Maldigestion and/or Malabsorption in Mice.

  2019cites this paper
• Amyloid pathology disrupts gliotransmitter release in astrocytes

  2019cites this paper
• Deletion of calcineurin from GFAP-expressing astrocytes impairs excitability of cerebellar and hippocampal neurons through astroglial Na+/K+ ATPase

  2019cites this paper
• Group 1 metabotropic glutamate receptors trigger glutamate-induced intracellular Ca2+ signals and nitric oxide release in human brain microvascular endothelial cells

  2019cites this paper
• Astrocytes: Role and Functions in Brain Pathologies

  2019cites this paper
• Astroglia in Alzheimer's Disease.

  2019cites this paper
• Conjugated polymers optically regulate the fate of endothelial colony-forming cells

  2019cites this paper
• Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications

  2019cites this paper
• ApoE4 pathology in Alzheimer's disease from the perspective of organelle dysfunction in astrocytes

  2019influential citation
• L’astrocyte, intégrateur et régulateur de l'activité synaptique excitatrice dans des conditions physiologiques et pathologiques.

  2019cites this paper
• Correction: Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model

  2019cites this paper
• Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders

  2019cites this paper